CurrentRegence BlueCross BlueShieldPolicy 220

Surgical Treatments for Lymphedema and Lipedema

Customize your policy alerts

Sign up for regence Policy 220 alerts

Get alerted when Policy 220 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs coverage and medical-necessity determinations for liposuction, lipectomy, and lymphatic surgical procedures used to treat or prevent lymphedema or lipedema. It applies to providers submitting these services for review under applicable member contracts.

Policy Summary

PayerRegence BlueCross BlueShield

PolicySurgical Treatments for Lymphedema and Lipedema

Policy CodePolicy 220

Change TypeNo material change

Effective DateJanuary 1, 2027

Last ReviewSep 1, 2026

Next Review DateJune 1, 2027

Key ActionDocument no response to at least six consecutive months of conservative therapy, including compression therapy and complex decongestive therapy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentRegence BlueCross BlueShieldPolicy 220

Surgical Treatments for Lymphedema and Lipedema

Customize your policy alerts

Sign up for regence Policy 220 alerts

Get alerted when Policy 220 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerRegence BlueCross BlueShield

PolicySurgical Treatments for Lymphedema and Lipedema

Policy CodePolicy 220

Change TypeNo material change

Effective DateJanuary 1, 2027

Last ReviewSep 1, 2026

Next Review DateJune 1, 2027

Key ActionDocument no response to at least six consecutive months of conservative therapy, including compression therapy and complex decongestive therapy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6 monthsMinimum conservative therapy before eligible lipedema surgery

BMI >35BMI threshold for additional weight-loss documentation

5 litersMaximum aspirate in the surgical plan

InvestigationalPhysiologic microsurgery for lymphedema and prevention

Criteria requiredLiposuction for lipedema

Coverage Criteria

Medically Necessary Lipedema Extremity Surgery

Liposuction or lipectomy to treat lipedema of the extremities may be considered medically necessary when ALL of the following criteria are met:

ALL of the following

Surgery is performed by a hospital-credentialed, board-certified plastic surgeon.
The individual has a diagnosis of lipedema documented during an in-person examination, with ALL of the following findings
- Bilateral symmetric adiposity disproportionately affecting the extremities compared with the trunk, neck, chest, abdomen, and/or pelvis, with minimal involvement of the hands and feet.
- Non-pitting edema of all extremities included in the planned procedure.
- Pain and tenderness on palpation of all affected areas included in the planned procedure.
- Negative Stemmer sign on all extremities included in the planned procedure.
- Photographs documenting bilateral symmetric adiposity disproportionately affecting the extremities compared with the trunk, unaffected hands and feet, and an appearance consistent with lipedema.
There is documentation of significant physical functional impairment, such as difficulty ambulating or performing activities of daily living.
The individual has not responded to at least six consecutive months of optimal medical management, including complex decongestive therapy and compression therapy.>= 6 consecutive months
For an individual with BMI greater than 35 kg/m², medically supervised weight-loss measures have had no effect on lipedema-affected areas, as documented through nutrition and/or medical interventions with clinic visits over six consecutive months.BMI > 35 kg/m²; >= 6 consecutive months
The postoperative plan of care includes continued use of compression garments as instructed to maintain treatment benefits.
The area requested for treatment has not previously been treated with liposuction or lipectomy.
The surgical plan indicates a maximum of 5 liters of aspirate will be removed.<= 5 liters

Investigational Lipedema Treatment Procedures

The following lipedema treatment procedures are considered investigational:

Any of the following

Liposuction or lipectomy to treat lipedema in areas other than the extremities, including the trunk or back.
Liposuction or lipectomy to treat lipedema when any of the medical-necessity criteria for extremity treatment are not met.

Investigational Lymphedema Treatment or Prevention

The following procedures for treating or preventing lymphedema are considered investigational:

Any of the following

Lymphatic physiologic surgery, with or without a microscope, to treat lymphedema, including lymphatico-lymphatic bypass, lymphatic-venous-lymphatic plasty, lymphovenous bypass, lymphaticovenous anastomosis, autologous lymph node transplantation, lysis of vein adhesions, and vascularized lymph node, omental, or other tissue transfer.
Lymphatic physiologic surgery, with or without a microscope, performed during nodal dissection, such as axillary or groin dissection, or during breast reconstruction to prevent lymphedema in individuals being treated for breast cancer, including the Lymphatic Microsurgical Preventing Healing Approach.
Liposuction or lipectomy to treat lymphedema, including lipectomy, suction-assisted protein lipectomy, liposuction, and lymph-sparing liposuction.

Medically Necessary Lipedema Liposuction

Liposuction, including lipectomy, suction-assisted protein lipectomy, and lymph-sparing liposuction, may be considered medically necessary for lipedema when the applicable medical-necessity criteria are met.

Medical necessity requires

Treatment is directed at lipedema of the extremities.
All criteria for medically necessary lipedema extremity surgery are met, including the required diagnosis and examination findings, functional impairment, failed conservative management, applicable weight-loss documentation, postoperative compression plan, untreated requested area, and maximum aspirate limit.

Investigational Lipedema Liposuction

Lipedema liposuction or lipectomy is investigational when the medical-necessity requirements are not satisfied or when treatment is directed outside the extremities.

Criteria not met or non-extremity treatment

One or more required criteria for medically necessary lipedema extremity surgery is not met.
The requested treatment area is outside the extremities, including the trunk or back.

Investigational Lymphedema Surgery

Lymphedema surgery is considered investigational for all indications, including treatment and prevention.

Investigational procedures

Physiologic microsurgery for lymphedema, including lymphatico-lymphatic bypass, lymphatic-venous-lymphatic plasty, lymphovenous bypass, lymphaticovenous anastomosis, autologous lymph node transplantation, or vascularized lymph node transfer.
Other lymphatic physiologic surgery, with or without a microscope, including lysis of vein adhesions or vascularized lymph node, omental, or other tissue transfer.
Physiologic lymphatic microsurgery performed during nodal dissection or breast reconstruction to prevent lymphedema, including the Lymphatic Microsurgical Preventing Healing Approach.
Liposuction or lipectomy for lymphedema, including suction-assisted protein lipectomy and lymph-sparing liposuction.

Additional investigational coverage statements apply to lipedema and lymphatic surgery. Liposuction or lipectomy for lipedema outside the extremities is investigational, as is treatment when the medical-necessity criteria are not met. Lymphatic physiologic surgery and lymphedema liposuction or lipectomy are also investigational.

Liposuction or lipectomy for lipedema in areas other than the extremities, including the trunk or back, is considered investigational.

Physiologic microsurgeries for lymphedema are considered investigational, including lymphatico-lymphatic bypass, lymphatic-venous-lymphatic plasty, lymphovenous bypass, lymphaticovenous anastomosis, autologous lymph node transplantation, and vascularized lymph node transfer. Lymphatic physiologic surgery performed during nodal dissection or breast reconstruction to prevent lymphedema is also investigational.

Preventive lymphatic physiologic microsurgery performed during nodal dissection, such as axillary or groin dissection, or during breast reconstruction to prevent lymphedema in individuals being treated for breast cancer, including the Lymphatic Microsurgical Preventing Healing Approach, is considered investigational.

Reporting CPT 38999 for treatment of lipedema is not appropriate because lipedema is not a disease of the lymphatic system.

Reporting CPT 15839 for body parts represented by another, more specific code, such as the thigh or leg, is not appropriate.

Coding and Policy Thresholds

Coding guidanceCPT

15839

Reporting for body parts represented by other specific codes, such as thigh or leg, is not appropriate.

CodesCPT

1019T	Lymphovenous bypass, including robotic assistance, when performed, per extremity.
1081T	Microvascular anastomosis between a lymph node and a vein, including robot assistance, when performed; initial anastomosis.
1082T	Microvascular anastomosis between a lymph node and a vein, including robot assistance, when performed; each additional anastomosis (List separately in addition to code for primary procedure).
15832	Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh.
15833	Excision, excessive skin and subcutaneous tissue (includes lipectomy); leg.
15834	Excision, excessive skin and subcutaneous tissue (includes lipectomy); hip.
15835	Excision, excessive skin and subcutaneous tissue (includes lipectomy); buttock.
15836	Excision, excessive skin and subcutaneous tissue (includes lipectomy); arm.
15837	Excision, excessive skin and subcutaneous tissue (includes lipectomy); forearm or hand.
15838	Excision, excessive skin and subcutaneous tissue (includes lipectomy); submental fat pad.

1–10 of 16

1/2

Conservative therapy duration

Required durationAt least six consecutive months

Required therapyOptimal medical management, including complex decongestive therapy and compression therapy

Required documentationDocument no response to the minimum six months of conservative therapy

Medically supervised weight-loss duration

ApplicabilityApplies when BMI is greater than 35 kg/m²

Required durationSix consecutive months

Provider Documentation and Action Items

Documentation Required

Six Months of Conservative Management

Document failure of at least six consecutive months of optimal medical management before requesting extremity liposuction or lipectomy for lipedema.

Include compression therapy and complex decongestive therapy (CDT), including manual lymph drainage, compression, and physical mobilization.

Documentation Required

Additional Weight-Loss Trial for BMI Above 35

For individuals with a BMI greater than 35 kg/m², document six consecutive months of medically supervised weight-loss measures and their lack of effect on the lipedema-affected areas.

Include nutrition and/or medical interventions with clinic visits in the medical record.

Documentation Required

Clinical Background

Lymphedema is fluid accumulation caused by disruption of lymphatic drainage. It may be primary, resulting from congenital or inherited lymphatic abnormalities, or secondary to acquired lymphatic damage, such as cancer treatment or trauma. Secondary lymphedema is evaluated through history and physical examination, including assessment of localized progressive edema and asymmetric limb measurements after other causes of edema have been excluded; imaging may help distinguish lymphedema from other causes in diagnostically challenging cases. Lipedema is a distinct condition involving increased subcutaneous fat with non-pitting, bilateral extremity swelling and may be painful or mistaken for obesity or lymphedema. Conservative management may include compression therapy, manual lymphatic drainage, physical mobilization, and complex decongestive therapy.

Definitions

Lymphedema

DefinitionAccumulation of fluid caused by disruption of lymphatic drainage

Primary causeCongenital or inherited abnormalities in the lymphatic system

Secondary causeAcquired damage to the lymphatic system

Lipedema

DefinitionA rare condition in which increased fat tissue accumulates under the skin

Characteristic swellingNon-pitting, bilateral swelling in the extremities

Typical presentationUsually affects the lower extremities but may also affect the upper extremities

Policy Summary

PayerRegence BlueCross BlueShield

PolicySurgical Treatments for Lymphedema and Lipedema

Policy CodePolicy 220

Change TypeNo material change

Effective DateJanuary 1, 2027

Last ReviewSep 1, 2026

Next Review DateJune 1, 2027

Key ActionDocument no response to at least six consecutive months of conservative therapy, including compression therapy and complex decongestive therapy.

SourceLink

On This Page

Medically supervised weight loss through nutrition and/or medical interventions with clinic visits

Maximum aspirate

Maximum aspirate5 liters

Required planThe surgical plan must indicate the amount of aspirate to be removed

Postoperative careThe postoperative plan must include continued compression therapy

BMI threshold

BMI thresholdGreater than 35 kg/m²

Additional requirementDocument six consecutive months of medically supervised weight-loss measures

Outcome requiredWeight-loss measures must have had no effect on lipedema-affected areas

Clinical and Provider Documentation

Submit the clinical and provider documentation needed to establish eligibility and support medical necessity for the requested procedure.

History and physical or chart notes.
Documentation that the surgeon is a hospital-credentialed, board-certified plastic surgeon.
Documentation supporting the lipedema diagnosis, including the policy-defined clinical examination findings and required photographs.

Documentation Required

Functional Impairment

Document significant physical functional impairment caused by the affected areas and identify the activities of daily living that are impaired.

Describe specific limitations involving walking, feeding, dressing or grooming, toileting, bathing, or transferring, as applicable.

Documentation Required

Conservative Treatment Failure

Document lack of response to at least six months of conservative treatment before requesting surgery.

Address both compression therapy and complex decongestive therapy (CDT).
Describe the components of CDT used, such as manual lymph drainage, compression therapy, and physical mobilization.

Documentation Required

Weight-Loss Documentation

When BMI exceeds 35 kg/m², document the effect of medically supervised weight loss on the lipedema-affected areas.

Document nutrition and/or medical interventions with clinic visits over six consecutive months and indicate whether the affected areas changed.

Documentation Required

Postoperative Plan and Aspirate Volume

The surgical plan must specify continued postoperative compression therapy and the planned amount of aspirate to be removed.

Document that compression garments will continue as instructed to maintain treatment benefits.
Specify a maximum of 5 liters of aspirate.

Denial Risk

Non-Extremity Lipedema Treatment

Liposuction or lipectomy for lipedema in areas other than the extremities is considered investigational.

This includes treatment of the trunk, back, or other non-extremity areas.

Denial Risk

Lipedema Criteria Not Met

Liposuction or lipectomy for lipedema is considered investigational when any medical-necessity criterion in Criterion I is not met.

Ensure all applicable clinical, functional, treatment-failure, weight-loss, postoperative, prior-treatment, and aspirate-volume requirements are documented.

Denial Risk

Physiologic Lymphedema Surgery

Lymphatic physiologic surgery to treat lymphedema is considered investigational, whether or not a microscope is used.

Includes lymphatico-lymphatic bypass, lymphatic-venous-lymphatic plasty, lymphovenous bypass, lymphaticovenous anastomosis, autologous lymph node transplantation, vascularized lymph node or other tissue transfer, lysis of vein adhesions, and related procedures.

Denial Risk

Preventive Lymphatic Surgery

Preventive lymphatic physiologic surgery performed during nodal dissection or breast reconstruction to prevent lymphedema is considered investigational.

This includes procedures such as the Lymphatic Microsurgical Preventing Healing Approach in individuals being treated for breast cancer.

Denial Risk

Lymphedema Liposuction or Lipectomy

Liposuction or lipectomy to treat lymphedema is considered investigational.

Includes suction-assisted protein lipectomy, lymph-sparing liposuction, lipectomy, and related liposuction procedures.

Denial Risk

Lipedema Criteria Not Met

Liposuction for lipedema is considered investigational when the policy medical-necessity criteria are not met.

This includes lipectomy, suction-assisted protein lipectomy, and lymph-sparing liposuction.

Denial Risk

Non-Extremity Lipedema Treatment

Liposuction for lipedema in areas outside the extremities is considered investigational.

Do not treat the trunk, back, or other non-extremity areas as eligible under the extremity lipedema criteria.

Denial Risk

Physiologic Microsurgery for Lymphedema

Physiologic microsurgery for lymphedema is considered investigational for all indications.

Includes lymphatico-lymphatic bypass, lymphatic-venous-lymphatic plasty, lymphovenous bypass, lymphaticovenous anastomosis, autologous lymph node transplantation, vascularized lymph node transfer, and related procedures.

Denial Risk

Preventive Lymphatic Microsurgery

Preventive lymphatic microsurgery performed during nodal dissection or breast reconstruction to prevent lymphedema is considered investigational.

This includes the Lymphatic Microsurgical Preventing Healing Approach and related procedures for individuals being treated for breast cancer.

Denial Risk

Lymphedema Liposuction

Liposuction for treatment of lymphedema is considered investigational.

Includes lipectomy, suction-assisted protein lipectomy, and lymph-sparing liposuction.

Billing Rule

Avoid Inappropriate Unlisted or Nonspecific Coding

Use the specific applicable procedure code rather than an unlisted or nonspecific code when reporting treatment for lipedema or a specific body part.

Do not report 38999 for lipedema; it is not a disease of the lymphatic system.
Do not report 15839 for a body part represented by another specific code, such as the thigh or leg.

Complex decongestive therapy (CDT)

DefinitionA multiphase conservative treatment program

Manual lymph drainageA massage technique used to move fluid from obstructed areas into functioning lymph vessels and lymph nodes

Other componentsCompression therapy and physical mobilization

LYMPHA

PurposePrevent lymphedema during breast cancer treatment

TimingPerformed during nodal dissection or reconstructive surgery

TechniqueArm lymphatics are anastomosed to a collateral branch of an axillary vein

Lymphovenous anastomosis (LVA) / lymphovenous bypass

Procedure typeA physiologic microsurgical procedure

PurposeReconstructs or bypasses obstructed lymphatic vessels

Vascular system usedUses the venous system

Vascularized lymph node transfer (VLNT)

Procedure typeA lymph tissue transfer procedure

Tissue transferredVascularized lymph nodes

PurposeUsed to treat lymphedema